-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

622. Lymphomas: Translational – Non-Genetic: Poster II

Symposia: Lymphomas: Translational – Non-Genetic Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Jun Ma, PhD1*, Michael P Randall, MD2, Ming Lu2*, Lingjing Chen, PhD2*, Huimin Geng, PhD3*, Aishwarya Kumar1*, Saloni Malla, PhD1*, Mark Noviski, PhD1*, Ryan Rountree, PhD1* and James L. Rubenstein, MD, PhD4

1NURIX Therapeutics, San Francisco, CA
2Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA
3Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA
4Hematology/Oncology, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA

Vinodh Pillai, MD1*, David Smith, PhD2*, Anna Eichinger3,4*, Andrew Rech5*, Julia Wang5*, Eduardo Esteva6*, Arta Seyedian7*, Xiaoxu Yang8*, Mei Zhang9*, Dan Martinez10*, Kai Tan, PhD11, Minjie Luo, PhD, FACMG12*, Christopher Y. Park, MD, PhD13 and Boris Reizis, PhD14*

1University of Pennsylvania, Philadelphia, PA
2Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA
3New York University Grossman School of Medicine, New York, NY
4Department of Pediatrics, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
5University of Pennsylvania, Philadelphia
6New York University Grossman School of Medicine, New York
7Children's Hospital of Philadelphia, Philadelphia, PA
8The Children's Hospital of Philadelphia, Philadelphia, PA
9The Children's Hospital of Philadelphia, Philadelphia
10The Children's Hospital of Philadelphia, Phildelphia
11Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA
12Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Philadelphia
13Department of Pathology, New York University School of Medicine, New York, NY
14New York University School of Medicine, New York, NY

Marina Bacac, PhD1*, Johannes Sam, PhD2*, Won Seog Kim, MD3*, Gareth P. Gregory, MBBS(Hons), PhD, FRACP, FRCPA4, Matthew Ku, MBBS, PhD5*, Sylvia Herter, PhD1*, Christian Klein, PhD1, Pablo Umana, PhD1, Stephen Simko6*, Victor Orellana-Noia6*, Linda Lundberg7* and Alessia Bottos, PhD7*

1Roche Innovation Center Zürich, Pharma Research & Early Development, Zürich, Switzerland
2Roche Innovation Center Zürich, Pharma Research & Early Development, Zurich, Switzerland
3Samsung Medical Center, Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
4School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia
5St Vincent's Hospital, University of Melbourne, Melbourne, Australia
6Genentech, Inc., South San Francisco, CA
7F. Hoffmann-La Roche Ltd, Basel, Switzerland

Johannes Duell, MD1*, Diana Alvarez Arias2*, Hilka Rauert-Wunderlich1*, Florian Eisele1*, Alla Volgina2*, Beth Rumberger2*, Thomas Stauffer Larsen, MD, PhD3* and Andreas Rosenwald1*

1University of Wurzburg, Wurzburg, Germany
2Incyte Corporation, Wilmington, DE
3Odense University Hospital, Odense, Denmark

Dimitra Karagkouni, PhD1,2,3*, Maria J. J. Fernandez Turizo, MD4, Nikolaos Kalavros1,2,3,5*, Sean M McCabe, BS6*, Alexandra W Lenart, BA7*, Shivani Nanda1,2,3*, Athanasios Ploumakis1,2,3,5*, Antonella Amaral2,5*, Anna B Rider, BSc8*, Aliyah R. Sohani, MD3,6*, Mwanasha H. Merrill, MD9, Eric D. Jacobsen, MD10, Maria Elena Cabrera, MD11*, Pablo Villegas12*, Ioannis S Vlachos, PhD1,2,3,5* and Salvia Jain, MD2,3,6

1Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA
2Broad Institute of Harvard and MIT, Cambridge, MA
3Harvard Medical School, Boston, MA
4Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Brookline, MA
5Spatial Technologies Unit, Harvard Medical School Initiative for RNA Medicine, Beth Israel Deaconess Medical Center, Boston, MA
6Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA
7Department of Medicine, Massachusetts General Hospital, Boston, MA
8Department of Pathology, Massachusetts General Hospital, Boston, MA
9Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
10Dana Farber Cancer Institute, Boston, MA
11Hematology Department, Hospital del Salvador, Santiago, Chile
12Pathology Department, Hospital del Salvador, Santiago, Chile

Troy Noordenbos1,2*, Joseph G. Schroers-Martin, MD1, Mark P. Hamilton, MD, PhD3,4, Soyeong Jun, PhD5*, Takeshi Sugio, MD, PhD1,2*, Brian J. Sworder, MD, PhD6, Chloé Beate Steen, PhD7*, Mari Olsen, BS1*, Chih Long Liu, PhD1*, Aaron Newman8*, Brooke Howitt, MD, PhD9*, Yasodha Natkunam, MD, PhD9, David B. Miklos, MD, PhD3,10, Maximilian Diehn, MD, PhD5*, Matthew J. Frank, MD, PhD2,3,10 and Ash A. Alizadeh, MD, PhD1,2

1Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
2Stanford Cancer Institute, Stanford University, Stanford, CA
3Stanford Cancer Institute, Center for Cancer Cell Therapy, Stanford University, Stanford, CA
4Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
5Department of Radiation Oncology, Stanford University, Stanford, CA
6Division of Hematology and Oncology, University of California, Irvine, Irvine, CA
7Oslo University Hospital, Oslo, Norway
8Stanford University, Stanford, CA
9Department of Pathology, Stanford University, Stanford, CA
10Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA

Lei Nie, MD1,2*, Vivian Jiang, PhD1, Yang Liu, Ph.D1,3*, Tianci Zhang, MS1*, Hong Kim, PhD4*, Jovanny Vargas5*, Qingsong Cai, PhD3*, Selvi Thirumurthi, MD6*, David Santos4* and Michael Wang, MD1,7,8

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, HOUSTON, TX
3The University of Texas MD Anderson Cancer Center, Houston, TX
4UT MD Anderson Cancer Center, Houston, TX
5Lymphoma Myeloma, The University of Texas MD Anderson Cancer Center, houston, TX
6Gastroenterology, The University of Texas MD Anderson Cancer Center, houston, TX
7Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
8The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, TX

Patrick Nylund, PhD1*, Kossi D Abalo, PhD1,2*, Saima Zubair, PhD1*, Eirini Voutsinou1*, Tove Selvin1*, Ann-Marie Ly, MD1*, Anna Nikkarinen, MD3*, Mattias Berglund, PhD4*, Daniel Molin4*, Gunilla Enblad, MD, PhD4*, Peter Hollander, MD, PhD4*, Mats Hellström, MD, PhD4* and Ingrid Glimelius, MD, PhD1,2

1Department of Immunology, Genetics and Pathology, Cancer Precision Medicine Unit, Uppsala University, Uppsala, Sweden., Uppsala University, Uppsala, Sweden
2Department of Medicine, Clinical Epidemiology Division, Karolinska Institute, Stockholm, Sweden
3Department of Immunology, Genetics and Pathology, Cancer Precision Medicine Unit, Uppsala University, Uppsala, Sweden
4Department of Immunology, Genetics and Pathology, Cancer Immunotherapy Unit, Uppsala University, Uppsala, Sweden

Meijuan Wu1*, Xi Chen2*, Jialiang Lu3,4*, Weihao Zhuang3*, Chang He5*, Cong Li2*, Haifeng Yu2*, Tao Lei2*, Xiaowu Dong, PhD3*, Jianpeng Sheng, PhD5* and Haiyan Yang, PhD6

1Pathology Department, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China
2Lymphoma Department, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China
3Hangzhou Institute of Innovative Medicine, Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
4Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China
5College of Artificial Intelligence, Nanjing University of Aeronautics and Astronautics, Nanjing, China
6Department of Lymphoma, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China

Marie Hairing Enemark1*, Maja Lund Jensen, MSc1*, Maja Dam Andersen, MD2*, Trine Plesner3*, Stephen Hamilton-Dutoit2* and Maja Ludvigsen1,4

1Department of Hematology, Aarhus University Hospital, Aarhus N, Denmark
2Aarhus University Hospital, Aarhus N, Denmark
3Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
4Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark

Daisy Lin, MS*, Vanessa Spires*, Jeremy Gale, MS*, Nathan Cheadle, MS*, Tine Casneuf, PhD*, Gregg Masters, MS*, Lisa Grimm, BS*, Omar Jabado, PhD*, Tahamtan Ahmadi, MD, PhD*, Mark Fereshteh, PhD*, Maria Jure-Kunkel, PhD, DVM*, Andrew J. Steele, PhD* and Jordan Blum, PhD*

Genmab, Plainsboro, NJ

Ioanna Xagoraris, MD1,2, Ying Yang, PhD3*, Dora Trogrlic, MSc3*, Alma Mansson4*, Christina Plastira, MD3*, Vasiliki Leventaki, MD5*, Hong Qian, PhD6, Andreas Lundqvist, PhD3* and George Z. Rassidakis, MD, PhD3,7*

1Department of Oncology-Pathology, Karolinska Institute, Solna, Stockholm, Sweden
2Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden
3Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
4Center for Hematology and Regenerative Medicine (HERM), Department of Medicine, Huddinge, Karolinska Institute, Stockholm, Quebec, Sweden
5Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
6Center for Hematology and Regenerative Medicine (HERM), Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
7Department of Oncology-Pathology, Karolinska University Hospital, Stockholm, Sweden

Elisavet Vlachonikola, PhD1*, Antonios Mingos1,2*, Philip Rock3*, Glykeria Gkoliou1,2*, Marina Gerousi1*, Maria Fitopoulou1,2*, Nikolaos Pechlivanis1,4*, Maria Karipidou1*, Anastasia Iatrou1,2*, Malama Galanou1,5*, Efthalia Karamanli1*, Nikolaos Vastarouchas1*, Charles C Chu, PhD6, Clive S Zent, MD3, Richard Burack3, Anastasia Chatzidimitriou1,7* and Kostas Stamatopoulos1,7*

1Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
2Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece
3Departments of Pathology and Laboratory Medicine, Medicine, and Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
4Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece
5Department of Biological Applications and Technology, University of Ioannina, Ioannina, Greece
6Departments of Pathology and Laboratory Medicine, Medicine, and Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
7Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden

Anath Lionel, MD, PhD1, Naishu Kui2*, Ryan Sun2*, Eslam Aboismail, MD3*, Sanjit Om Tewari, MD4*, Ajlan Al Zaki, MD, PhD5, Sushanth Gouni, MD6, Preetesh Jain, MD, MBBS, PhD, DM6, Dai Chihara, MD, PhD6, Swaminathan P Iyer, MD6*, Michael Wang, MD6, Ranjit Nair, MD6*, Luis Enrique Malpica Castillo, MD6, Hun Ju Lee, MD6, Chijioke Nze, MD, MPH6, Luis E. Fayad, MD3, Frederick Hagemeister6*, Maria Alma Rodriguez, MD6*, Amy A. Ayers, MPH6*, Cristina Gutierrez7*, Gabriela Rondon, MD8, Fareed Khawaja, MBBS9, Partow Kebriaei, MD8, Elizabeth J. Shpall, MD8, Christopher R. Flowers, MD, MS6, Jason R. Westin, MD6, Paolo Strati, MD6, Wei WANG10*, Sa A. Wang, MD10, Sairah Ahmed, MD6 and Sattva S. Neelapu, MD6

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Oakville, ON, Canada
2Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
3The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Lymphoma/Myeloma and Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Critical Care, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Marina Gerousi1*, Maria Fitopoulou1,2*, Malama Galanou1,3*, Philip Rock4*, Georgios Karakatsoulis1*, Anastasia Anastasiadou1*, Maria Karipidou1*, Anastasia Iatrou1,2*, Efthalia Karamanli1*, Nikolaos Vastarouchas1*, Paolo Ghia, MD, PhD5,6, Charles C Chu, PhD7, Clive S Zent, MD4, Richard Burack4, Anastasia Chatzidimitriou1,8* and Kostas Stamatopoulos1,9

1Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
2Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece
3Department of Biological Applications and Technology, University of Ioannina, Ioannina, Greece
4Departments of Pathology and Laboratory Medicine, Medicine, and Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
5Division of Experimental Oncology, B cell neoplasia Unit, IRCCS Ospedale San Raffaele, Milan, Italy
6Università Vita-Salute San Raffaele, Milan, Italy
7Departments of Pathology and Laboratory Medicine, Medicine, and Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
8Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden
9Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

Ruifeng Sun1*, Jaewoong Lee, PhD1,2*, Mark E Robinson, PhD1*, Kohei Kume, PhD1*, Chuanzong Zhan, PhD1*, Zhangliang Cheng, BSc1*, Kadriye Nehir Cosgun, PhD1*, Lai N Chan, PhD1, Etienne Leveille, MD1*, Shalin Kothari, MD1*, Samuel G. Katz, MD-PhD3*, Ning Ma, PhD4*, Vivasvan S Vykunta5*, Brian Shy, MD-PhD6*, Daniel J Hodson, MD-PhD7, Alexander Marson, MD-PhD8*, Nagarajan Vaidehi, PhD4* and Markus Müschen, MD1

1Center of Molecular and Cellular Oncology, Yale University, New Haven, CT
2School of Biosystems and Biomedical Sciences, Korea University, Seoul, Korea, Republic of (South)
3Department of Pathology, Yale School of Medicine, New Haven, CT
4Department of Systems Biology, City of Hope Comprehensive Cancer Center, Duarte, CA
5Department of Medicine, University of California San Francisco, San Francisco, CA
6Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA
7Wellcome-MRC Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, United Kingdom
8Department of Medicine, University of California, San Francisco, San Francisco, CA

Min Liu1,2*, Liang Hong1*, Shruti Sridhar1*, Patrick Jaynes1*, Chartsiam Tipgomut, PhD1*, Limei Poon3,4*, Sanjay De Mel, BSc, FRCPath, MRCP3,4*, Joanne Shu Xian Lee4,5*, Jayalakshmi .5*, Siok-Bian Ng4,6*, Char Loo Tan6*, Wee-Joo Chng1,5,7 and Anand Devaprasath D. Jeyasekharan, MBBS, MRCP, PhD1,3,4,8*

1Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
2Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, China
3Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore
4NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
5Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
6Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
7Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
8Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Jenny Coelho1, Sophia Maharry Roush2*, Samantha Beck3, Amon Chirwa4*, Edwards Kasonkanji, MPH4*, Tamiwe Tomoka, MD5*, Jonathan Galeotti6*, Satish Gopal, MD, MPH7,8*, Matthew S Painschab, MD4 and Yuri D. Fedoriw, MD4,9

1Department of Laboratory Medicine, UNC Chapel Hill, Chapel Hill, NC
2Pathobiology & Translational Science, University of North Carolina at Chapel Hill, Chapel Hill, NC
3Pathobiology & Translational Science, University of North Carolina at Chapel Hill, Carrboro, NC
4UNC Project-Malawi, Lilongwe, Malawi
5Kamuzu Central Hospital, Lilongwe, Lilongwe, MWI
6University of North Carolina, Chapel Hill, NC
7UNC Project-Malawi, Lilongwe, MWI
8National Cancer Institute, Rockville, MD
9Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC

Fiona Swain1,2*, Melinda Burgess, PhD2,3*, Sarah Kempe4*, Muhammed B. Sabdia, BSc5, Andrea S Henden, MBBS6,7,8, Joel Wight, MBBS, FRACP, FRCPA, DMedSc9,10*, Eliza A. Hawkes, MD11,12, Howard Mutsando, MBChB, FRACP, FRCPA13,14*, Dipti Talaulikar, PhD, FRACP, FRCPA, MBBS15,16, Lilia Merida de Long4*, Simone Birch, MBBS17*, Penelope Wyche, MBBS18*, Zachary Hawula, PhD2*, Rakin Chowdhury, MD2,19*, Maher K. Gandhi, PhD, FRACP, FRCPath5,20 and Colm Keane, MD2,21

1Department of Haematology, Princess Alexandra Hospital, Woolloongabba, Australia
2Frazer Institute, University of Queensland, Brisbane, QLD, Australia
3Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia
4Frazer Institute, University of Queensland, Brisbane, Australia
5Mater Research Institute, University of Queensland, Brisbane, QLD, Australia
6Translational Cancer Immunotherapy, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
7Department of Haematology and Bone Marrow Transplant, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
8Faculty of Medicine, University of Queensland, Brisbane, Australia
9Department of Haematology & Bone Marrow Transplantation, Townsville University Hospital, Townsville, Australia
10School of Medicine, James Cook University, Townsville, Australia
11School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
12Austin Health, Olivia Newton-John Cancer Research & Wellness Centre, Melbourne, Australia
13University of Queensland Rural Clinical School, Toowoomba, QLD, Australia
14Toowoomba Hospital, Toowoomba, QLD, Australia
15Department of Diagnostic Genomics, Canberra Health Services, Canberra, Australia
16College of Health and Medicine, Australian National University, Red Hill, Australia
17Pathology Queensland, Brisbane, AUS
18Pathology Queensland, Brisbane, Australia
19Department of Haematology, Princess Alexandra Hospital, Fairfield Gardens, QLD, Australia
20Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia
21Department of Haematology, Princess Alexandra Hospital, Woolloongabba, Qld, Australia

*signifies non-member of ASH